István Alpek
Direttore Finanziario/CFO presso Primus Capital Kockázati Tökealap-kezelö Zrt.
Profilo
István Alpek is currently the Director at BBS Nanotechnológia Kutatási.
és Fejlesztési Kft.
and the Partner & Chief Financial Officer at Primus Capital Kockázati Tökealap-kezelö Zrt.
He was previously the Investment Director at 3TS Capital Partners (Hungary) from 2003 to 2006.
Posizioni attive di István Alpek
| Società | Posizione | Inizio |
|---|---|---|
BBS Nanotechnológia Kutatási és Fejlesztési Kft.
 BBS Nanotechnológia Kutatási és Fejlesztési Kft. Pharmaceuticals: MajorHealth Technology BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary. | Direttore/Membro del Consiglio | - |
Primus Capital Kockázati Tökealap-kezelö Zrt.
 Primus Capital Kockázati Tökealap-kezelö Zrt. Investment ManagersFinance Primus Capital Kockázati Tökealap-kezelö Zrt. (Primus Capital) is the venture capital subsidiary of MKB Bank Nyrt. The firm was founded by Zoltán Bruckner in 2003, and is headquartered in Budapest, Hungary. (BSE:MKBBANK). | Direttore Finanziario/CFO | 01/04/2010 |
Precedenti posizioni note di István Alpek
| Società | Posizione | Fine |
|---|---|---|
| 3TS Capital Partners (Hungary) | Investitore di Private Equity | 31/12/2006 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Primus Capital Kockázati Tökealap-kezelö Zrt.
Primus Capital Kockázati Tökealap-kezelö Zrt. Investment ManagersFinance Primus Capital Kockázati Tökealap-kezelö Zrt. (Primus Capital) is the venture capital subsidiary of MKB Bank Nyrt. The firm was founded by Zoltán Bruckner in 2003, and is headquartered in Budapest, Hungary. (BSE:MKBBANK). | Finance |
BBS Nanotechnológia Kutatási és Fejlesztési Kft.
BBS Nanotechnológia Kutatási és Fejlesztési Kft. Pharmaceuticals: MajorHealth Technology BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary. | Health Technology |
| 3TS Capital Partners (Hungary) | Finance |
- Borsa valori
- Insiders
- István Alpek
